InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (11 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Bitterman Kevin, Director. Director active across 3 companies, notably Akero Therapeutics, Inc.. In total, 15 filings have been published. Breakdown: 1 buy · 11 sells. Total volume traded: €22.7m. Activity tracked since 1 June 2021. The latest transaction was filed on 22 August 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations15 total
2,287 shares@ US$61.030.6% of flowCommon StockSEC:0001415889-25-023049:0
395 shares@ US$60.95Common StockSEC:0001415889-25-021281:0
8,492 shares@ US$61.042.0% of flowCommon StockSEC:0001415889-25-020863:0
29,837 shares@ US$60.977.1% of flowCommon StockSEC:0001415889-25-020295:0
664 shares@ US$61.130.2% of flowCommon StockSEC:0001415889-25-020127:0
222,223 shares@ US$36.0036.6% of flowCommon StockSEC:0001415889-24-017727:0
Ideal exit: 14 Mar 2025 (T+270)
26,157 shares@ US$73.508.7% of flowCommon StockSEC:0001415889-24-007190:0
82,500 shares@ US$67.6525.2% of flowCommon StockSEC:0001209191-24-002233:0
20,000 shares@ US$64.005.8% of flowCommon StockSEC:0001209191-24-001543:0
20,823 shares@ US$59.875.7% of flowCommon StockSEC:0001209191-23-058708:0
72,931 shares@ US$52.4017.2% of flowCommon StockSEC:0001209191-23-046252:0
16,544 shares@ US$26.2850.0% of flowCommon StockSEC:0001209191-21-037978:0
2,549,435 sharesCommon StockSEC:0001179110-16-018856:0
2,021,269 sharesCommon StockSEC:0001179110-16-018856:1
85,469 sharesCommon StockSEC:0001179110-16-018856:2
15 of 15 declarations
About Bitterman Kevin
Kevin Bitterman is a Board Member at Akero Therapeutics, Inc. He contributes to the strategic direction of the company, ensuring that decisions made by the board align with the company's growth objectives. His expertise in the biopharmaceutical field is an asset to the leadership team.
